Two Ohio counties struck a $260 million settlement Monday with three major drug distributors and a manufacturer over their role in fueling America's opioid epidemic. McKesson, AmerisourceBergen and Cardinal Health will pay the lion's share, while the generic drug maker Teva Pharmaceuticals will contribute $45 million. The deal allows them to avoid the nation's first major opioid proliferation trial — considered a bellwether for other cases — but they still face thousands of lawsuits by other local governments.
Where will the money go? Officials in Cuyahoga and Summit counties say they'll allocate the proceeds for social services and first responders on the front lines of the crisis.